Quantum Biopharma (QNTM) Research & Development (2020 - 2026)
Quantum Biopharma recorded quarterly Research & Development of $626092.0 in Q1 2026, up 789.28% quarter-over-quarter from $70404.0 in Q4 2025, and down 62.02% year-over-year from $1.6 million in Q1 2025.
Quantum Biopharma's Research & Development history runs 7 years deep, the most recent figure standing at $626092.0 for Q1 2026.
- In Q1 2026, Research & Development fell 62.02% year-over-year to $626092.0; the TTM figure through Mar 2026 stood at $1.7 million (down 49.56% YoY), while the FY2025 annual figure was $2.8 million, down 54.58% from the prior year.
- Research & Development came in at $626092.0 for Q1 2026 at Quantum Biopharma, up from $70404.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $2.3 million in Q1 2023 to a low of $32985.0 in Q3 2023.
- A 5-year average of $719517.2 and a median of $587644.5 in 2025 frame the typical range for Research & Development.
- On a YoY basis, Research & Development climbed as much as 2158.0% in 2024 and fell as far as 93.07% in 2024.
- Quantum Biopharma's Research & Development stood at $937052.0 in 2022, then tumbled by 96.48% to $32985.0 in 2023, then soared by 385.86% to $160260.0 in 2024, then sank by 56.07% to $70404.0 in 2025, then soared by 789.28% to $626092.0 in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $626092.0, $70404.0, and $495223.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 626,092.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 4.32 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -101.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 1.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 961.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -2.30 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.54 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 364.87 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 343.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 626,092.00 |
| Dec 31, 2025 | 70,404.00 |
| Sep 30, 2025 | 495,223.00 |
| Jun 30, 2025 | 549,197.00 |
| Mar 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | 160,260.00 |
| Sep 30, 2024 | 744,802.00 |
| Jun 30, 2024 | 897,986.00 |
| Mar 31, 2024 | 160,260.00 |
| Sep 30, 2023 | 32,985.00 |
| Mar 31, 2023 | 2.31 Mn |
| Mar 31, 2022 | 937,052.00 |
| Jun 30, 2021 | 3.61 Mn |
| Sep 30, 2020 | 3.50 Mn |
| Jun 30, 2020 | 1.13 Mn |
| Mar 31, 2020 | 226,299.20 |